COPD & Emphysema Support Group
COPD is a progressive disease characterized by airflow obstruction or limitation. Emphysema is characterized by loss of elasticity of the lung tissue, destruction of structures supporting the alveoli and of capillaries feeding the alveoli. Both have symptoms that include shortness of breath, among other respiratory troubles. If you are a COPD or Emphysema sufferer, join...
Is this questionnaire something in place of PFT's, in conjunction with PFTs or used to evaluate PFTs? Deb
Developed by Paul Jones at St. George's Hospital in London in 1990, this measure is a disease-specific instrument designed to measure impact on overall health, daily life, and perceived well-being. It was developed for use by patients with fixed and reversible airway obstruction. The measure consists of 50 (76 responses) items that produce three domain scores and one overall score measuring:
Symptom (frequency and severity); Activity (activities that cause or are limited by breathlessness); and Impacts (social functioning, psychological disturbances resulting from airways disease).
It is important to note that Section I (Symptoms) contains items on a five-point Likert scale; Sections II (Activity) and III (Impacts) are dichotomous (yes/no) items.
Hope this helps,
Hugs, Holly
The information is combined.